Thyroid tumor: People with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not use tirzepatide due to the potential risks of thyroid tumors
The regulatory landscape governing compounded medications is subject to change
Others may discover that their recovery times are faster, perhaps because the body is nourished and not expending as much effort handling hunger
It can affect their overall progress
If we can target the treatment there, we may be able to maintain the positive effects while reducing side effects," says Jlia Teixidor-Deulofeu, first author of the study and PhD student at Sahlgrenska Academy at the University of Gothenburg
Shitara K, Fleitas T, Kawakami H, Curigliano G, Narita Y, Wang F, et al